Health News, Delhi- Magazine: Research Institute of Influenza in St. Petersburg has completed preclinical trials of a new vaccine against coronavirus.
There are now five COVID-19 vaccines registered in Russia . The first of these, Sputnik V , developed by the Gamaleya National Research Center for Epidemiology and Microbiology with the support of the RDIF , is widely used for mass vaccination and has been approved in 70 countries. Russians also have access to “EpiVacCorona” , created by the Novosibirsk center “Vector”, and “KoviVak” from the Chumakov Center of the Russian Academy of Sciences.
For revaccination, Sputnik Light is recommended – a light version of Sputnik V, which assumes a single injection of the drug. Last week, the Ministry of Health registered EpiVacCoron-N – this vaccine has the same active ingredient as in EpiVacCoron, but they are synthesized in different ways.